|
gptkbp:instanceOf
|
gptkb:investor
|
|
gptkbp:assetsUnderManagement
|
over €2 billion
|
|
gptkbp:country
|
gptkb:France
|
|
gptkbp:focusesOn
|
gptkb:biotechnology
healthcare
life sciences
medical devices
|
|
gptkbp:foundedYear
|
1972
|
|
gptkbp:founder
|
gptkb:Jean-Bernard_Schmidt
|
|
gptkbp:headquartersLocation
|
gptkb:Paris
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Sofinnova Partners
|
|
gptkbp:industry
|
venture capital
|
|
gptkbp:investedIn
|
early stage
growth stage
late stage
|
|
gptkbp:legalForm
|
Société par actions simplifiée (SAS)
|
|
gptkbp:managingPartner
|
gptkb:Antoine_Papiernik
gptkb:Denis_Lucquin
gptkb:Graziano_Seghezzi
gptkb:Henrijette_Richter
gptkb:Monica_Duca_Widmer
|
|
gptkbp:notableExit
|
Actelion (acquired by Johnson & Johnson)
CoreValve (acquired by Medtronic)
Corvidia Therapeutics (acquired by Novo Nordisk)
Novexel (acquired by AstraZeneca)
|
|
gptkbp:notableInvestment
|
gptkb:Actelion
gptkb:CoreValve
gptkb:DBV_Technologies
gptkb:ObsEva
gptkb:Ascendis_Pharma
gptkb:Corvidia_Therapeutics
gptkb:MD_Start
gptkb:Nexthink
gptkb:Novexel
gptkb:Pixium_Vision
|
|
gptkbp:numberOfEmployees
|
50+
|
|
gptkbp:officeLocation
|
gptkb:London
gptkb:Milan
gptkb:Paris
|
|
gptkbp:parentCompany
|
gptkb:Sofinnova_SA
|
|
gptkbp:regionServed
|
gptkb:Europe
gptkb:United_States
global
|
|
gptkbp:website
|
https://www.sofinnovapartners.com/
|
|
gptkbp:bfsParent
|
gptkb:Sofinnova_Investments
|
|
gptkbp:bfsLayer
|
6
|